Description: Spectral MD Holdings, Ltd. develops AI algorithms and optical technology for faster treatment decisions in wound care. Its products include DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. The company was incorporated in 2020 and is headquartered in Dallas, Texas.
Home Page: www.spectralmd.com
SMD Technical Analysis
2515 Mckinney Avenue
Dallas,
TX
75201
United States
Phone:
972 499 4934
Officers
| Name | Title |
|---|---|
| Mr. Wensheng Fan | Co-Founder, CEO & Exec. Director |
| Mr. Nils Windler | Chief Financial Officer |
| Dr. Niko Pagoulatos Ph.D. | Chief Operating Officer |
| Dr. Jeffrey Thatcher Ph.D. | Chief Scientist |
| Mr. Vincent S. Capone | Gen. Counsel & Corp. Sec. |
| Ms. Christine Marks | VP of Marketing & Commercialization |
| Dr. So-Jin Holohan Ph.D. | Head of UK/EU Clinical Research |
| Dr. Jeffrey Carter M.D. | Chief Medical Consultant |
| David Bronson | Financial Controller |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.8568 |
| Price-to-Sales TTM: | 2.0987 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 63 |